ID   1433B_HUMAN             Reviewed;         246 AA.
AC   P31946; A8K9K2; E1P616;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-OCT-2018, entry version 212.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Protein 1054;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=YWHAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Keratinocyte;
RX   PubMed=8515476; DOI=10.1006/jmbi.1993.1346;
RA   Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H.,
RA   Walbum E., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning and expression of the transformation sensitive
RT   epithelial marker stratifin. A member of a protein family that has
RT   been involved in the protein kinase C signalling pathway.";
RL   J. Mol. Biol. 231:982-998(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-11; 30-51; 63-73 AND 130-159, INTERACTION WITH
RP   PI4KB; TBC1D22A AND TBC1D22B, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23572552; DOI=10.1128/mBio.00098-13;
RA   Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L.,
RA   DeRisi J.L.;
RT   "ACBD3 interaction with TBC1 domain 22 protein is differentially
RT   affected by enteroviral and kobuviral 3A protein binding.";
RL   MBio 4:E00098-E00098(2013).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-11; 14-57; 63-70; 106-117; 130-169 AND 215-246,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT MET-1 AND THR-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Zebisch A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 3-20.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [10]
RP   INTERACTION WITH CRTC2.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [11]
RP   INTERACTION WITH YWHAB.
RX   PubMed=15538381; DOI=10.1038/sj.emboj.7600477;
RA   Schmidlin M., Lu M., Leuenberger S.A., Stoecklin G., Mallaun M.,
RA   Gross B., Gherzi R., Hess D., Hemmings B.A., Moroni C.;
RT   "The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by
RT   protein kinase B.";
RL   EMBO J. 23:4760-4769(2004).
RN   [12]
RP   INTERACTION WITH SSH1.
RX   PubMed=15159416; DOI=10.1083/jcb.200401136;
RA   Nagata-Ohashi K., Ohta Y., Goto K., Chiba S., Mori R., Nishita M.,
RA   Ohashi K., Kousaka K., Iwamatsu A., Niwa R., Uemura T., Mizuno K.;
RT   "A pathway of neuregulin-induced activation of cofilin-phosphatase
RT   Slingshot and cofilin in lamellipodia.";
RL   J. Cell Biol. 165:465-471(2004).
RN   [13]
RP   INTERACTION WITH ABL1.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [15]
RP   INTERACTION WITH YAP1.
RX   PubMed=17974916; DOI=10.1101/gad.1602907;
RA   Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., Xie J.,
RA   Ikenoue T., Yu J., Li L., Zheng P., Ye K., Chinnaiyan A., Halder G.,
RA   Lai Z.C., Guan K.L.;
RT   "Inactivation of YAP oncoprotein by the Hippo pathway is involved in
RT   cell contact inhibition and tissue growth control.";
RL   Genes Dev. 21:2747-2761(2007).
RN   [16]
RP   INTERACTION WITH ROR2, FUNCTION, PHOSPHORYLATION, DIMERIZATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17717073; DOI=10.1210/me.2007-0323;
RA   Liu Y., Ross J.F., Bodine P.V.N., Billiard J.;
RT   "Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-
RT   3(beta) phosphorylation and promotes osteoblast differentiation and
RT   bone formation.";
RL   Mol. Endocrinol. 21:3050-3061(2007).
RN   [17]
RP   INTERACTION WITH SIRT2.
RX   PubMed=18249187; DOI=10.1016/j.bbrc.2008.01.114;
RA   Jin Y.H., Kim Y.J., Kim D.W., Baek K.H., Kang B.Y., Yeo C.Y.,
RA   Lee K.Y.;
RT   "Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the
RT   activity of p53.";
RL   Biochem. Biophys. Res. Commun. 368:690-695(2008).
RN   [18]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [19]
RP   INTERACTION WITH SLITRK1.
RX   PubMed=19640509; DOI=10.1016/j.biopsych.2009.05.033;
RA   Kajiwara Y., Buxbaum J.D., Grice D.E.;
RT   "SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a
RT   phosphorylation-dependent manner.";
RL   Biol. Psychiatry 66:918-925(2009).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70 AND LYS-117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH AKAP13.
RX   PubMed=21224381; DOI=10.1074/jbc.M110.185645;
RA   Cariolato L., Cavin S., Diviani D.;
RT   "A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling
RT   complex involved in alpha1-adrenergic receptor-induced p38
RT   activation.";
RL   J. Biol. Chem. 286:7925-7937(2011).
RN   [25]
RP   INTERACTION WITH SOS1.
RX   PubMed=22827337; DOI=10.1042/BJ20120938;
RA   Saha M., Carriere A., Cheerathodi M., Zhang X., Lavoie G., Rush J.,
RA   Roux P.P., Ballif B.A.;
RT   "RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively
RT   regulating MAPK activation.";
RL   Biochem. J. 447:159-166(2012).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-2, ACETYLATION
RP   [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM SHORT), CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 UL46 (MICROBIAL INFECTION).
RX   PubMed=23938468; DOI=10.1074/mcp.M113.030866;
RA   Lin A.E., Greco T.M., Dohner K., Sodeik B., Cristea I.M.;
RT   "A proteomic perspective of inbuilt viral protein regulation: pUL46
RT   tegument protein is targeted for degradation by ICP0 during herpes
RT   simplex virus type 1 infection.";
RL   Mol. Cell. Proteomics 12:3237-3252(2013).
RN   [29]
RP   INTERACTION WITH MYO1C.
RX   PubMed=24636949; DOI=10.1016/j.jmb.2014.03.004;
RA   Stefan Munnich M.H., Manstein D.J.;
RT   "Crystal structure of human myosin 1c - the motor in GLUT4 exocytosis:
RT   implications for Ca(2+)-regulation and 14-3-3 binding.";
RL   J. Mol. Biol. 426:2070-2081(2014).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   INTERACTION WITH DAPK2.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with
RT   14-3-3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
RN   [32]
RP   INTERACTION WITH RIPOR2.
RX   PubMed=25588844; DOI=10.1242/jcs.161497;
RA   Gao K., Tang W., Li Y., Zhang P., Wang D., Yu L., Wang C., Wu D.;
RT   "Front-signal-dependent accumulation of the RHOA inhibitor FAM65B at
RT   leading edges polarizes neutrophils.";
RL   J. Cell Sci. 128:992-1000(2015).
RN   [33]
RP   ACETYLATION AT THR-2, AND CLEAVAGE OF INITIATOR METHIONINE.
RX   PubMed=25489052; DOI=10.1093/hmg/ddu611;
RA   Myklebust L.M., Van Damme P., Stoeve S.I., Doerfel M.J., Abboud A.,
RA   Kalvik T.V., Grauffel C., Jonckheere V., Wu Y., Swensen J., Kaasa H.,
RA   Liszczak G., Marmorstein R., Reuter N., Lyon G.J., Gevaert K.,
RA   Arnesen T.;
RT   "Biochemical and cellular analysis of Ogden syndrome reveals
RT   downstream Nt-acetylation defects.";
RL   Hum. Mol. Genet. 24:1956-1976(2015).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-239, IDENTIFICATION BY MASS
RP   SPECTROMETRY, INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
RN   [36]
RP   VARIANT ILE-99.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner. Negative
CC       regulator of osteogenesis. Blocks the nuclear translocation of the
CC       phosphorylated form (by AKT1) of SRPK2 and antagonizes its
CC       stimulatory effect on cyclin D1 expression resulting in blockage
CC       of neuronal apoptosis elicited by SRPK2. Negative regulator of
CC       signaling cascades that mediate activation of MAP kinases via
CC       AKAP13. {ECO:0000269|PubMed:17717073, ECO:0000269|PubMed:19592491,
CC       ECO:0000269|PubMed:21224381}.
CC   -!- SUBUNIT: Homodimer (PubMed:17717073). Interacts with SAMSN1 and
CC       PRKCE (By similarity). Interacts with AKAP13 (PubMed:21224381).
CC       Interacts with SSH1 and TORC2/CRTC2 (PubMed:15454081,
CC       PubMed:15159416). Interacts with ABL1; the interaction results in
CC       cytoplasmic location of ABL1 and inhibition of cABL-mediated
CC       apoptosis (PubMed:15696159). Interacts with ROR2 (dimer); the
CC       interaction results in phosphorylation of YWHAB on tyrosine
CC       residues (PubMed:17717073). Interacts with GAB2 (PubMed:19172738).
CC       Interacts with YAP1 (phosphorylated form) (PubMed:17974916).
CC       Interacts with the phosphorylated (by AKT1) form of SRPK2
CC       (PubMed:19592491). Interacts with PKA-phosphorylated AANAT
CC       (PubMed:11427721). Interacts with MYO1C (PubMed:24636949).
CC       Interacts with SIRT2 (PubMed:18249187). Interacts with the 'Thr-
CC       369' phosphorylated form of DAPK2 (PubMed:26047703). Interacts
CC       with PI4KB, TBC1D22A and TBC1D22B (PubMed:23572552). Interacts
CC       with the 'Ser-1134' and 'Ser-1161' phosphorylated form of SOS1
CC       (PubMed:22827337). Interacts (via phosphorylated form) with YWHAB;
CC       this interaction occurs in a protein kinase AKT1-dependent manner
CC       (PubMed:15538381). Interacts with SLITRK1 (PubMed:19640509).
CC       Interacts with SYNPO2 (phosphorylated form); YWHAB competes with
CC       ACTN2 for interaction with SYNPO2 (By similarity). Interacts with
CC       RIPOR2 (via phosphorylated form) isoform 2; this interaction
CC       occurs in a chemokine-dependent manner and does not compete for
CC       binding of RIPOR2 with RHOA nor blocks inhibition of RIPOR2-
CC       mediated RHOA activity (PubMed:25588844).
CC       {ECO:0000250|UniProtKB:Q9CQV8, ECO:0000269|PubMed:11427721,
CC       ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15454081,
CC       ECO:0000269|PubMed:15538381, ECO:0000269|PubMed:15696159,
CC       ECO:0000269|PubMed:17085597, ECO:0000269|PubMed:17717073,
CC       ECO:0000269|PubMed:17974916, ECO:0000269|PubMed:18249187,
CC       ECO:0000269|PubMed:19172738, ECO:0000269|PubMed:19592491,
CC       ECO:0000269|PubMed:19640509, ECO:0000269|PubMed:21224381,
CC       ECO:0000269|PubMed:22827337, ECO:0000269|PubMed:23572552,
CC       ECO:0000269|PubMed:24636949, ECO:0000269|PubMed:25588844,
CC       ECO:0000269|PubMed:26047703}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus
CC       1 protein UL46. {ECO:0000269|PubMed:23938468}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-359815, EBI-359815;
CC       Q76353:- (xeno); NbExp=3; IntAct=EBI-359815, EBI-6248077;
CC       Q9P0K1-3:ADAM22; NbExp=2; IntAct=EBI-359815, EBI-1567267;
CC       P15056:BRAF; NbExp=3; IntAct=EBI-359815, EBI-365980;
CC       P22681:CBL; NbExp=3; IntAct=EBI-359815, EBI-518228;
CC       O00257:CBX4; NbExp=2; IntAct=EBI-359815, EBI-722425;
CC       P30304:CDC25A; NbExp=10; IntAct=EBI-359815, EBI-747671;
CC       P30305:CDC25B; NbExp=5; IntAct=EBI-359815, EBI-1051746;
CC       P30307:CDC25C; NbExp=4; IntAct=EBI-359815, EBI-974439;
CC       O94921:CDK14; NbExp=5; IntAct=EBI-359815, EBI-1043945;
CC       P67828:CSNK1A1 (xeno); NbExp=3; IntAct=EBI-359815, EBI-7540603;
CC       Q9NYF0:DACT1; NbExp=4; IntAct=EBI-359815, EBI-3951744;
CC       Q13627-2:DYRK1A; NbExp=3; IntAct=EBI-359815, EBI-1053621;
CC       Q9UQC2:GAB2; NbExp=4; IntAct=EBI-359815, EBI-975200;
CC       P55040:GEM; NbExp=3; IntAct=EBI-359815, EBI-744104;
CC       P55041:Gem (xeno); NbExp=3; IntAct=EBI-359815, EBI-7082069;
CC       P56524:HDAC4; NbExp=3; IntAct=EBI-359815, EBI-308629;
CC       Q11184:let-756 (xeno); NbExp=2; IntAct=EBI-359815, EBI-3843983;
CC       Q5S007:LRRK2; NbExp=5; IntAct=EBI-359815, EBI-5323863;
CC       Q99759:MAP3K3; NbExp=2; IntAct=EBI-359815, EBI-307281;
CC       Q99683:MAP3K5; NbExp=3; IntAct=EBI-359815, EBI-476263;
CC       Q7KZI7:MARK2; NbExp=3; IntAct=EBI-359815, EBI-516560;
CC       P27448:MARK3; NbExp=4; IntAct=EBI-359815, EBI-707595;
CC       P26045:PTPN3; NbExp=4; IntAct=EBI-359815, EBI-1047946;
CC       P04049:RAF1; NbExp=18; IntAct=EBI-359815, EBI-365996;
CC       Q96TC7:RMDN3; NbExp=5; IntAct=EBI-359815, EBI-1056589;
CC       P61587:RND3; NbExp=2; IntAct=EBI-359815, EBI-1111534;
CC       P61588:Rnd3 (xeno); NbExp=5; IntAct=EBI-359815, EBI-6930266;
CC       P78362:SRPK2; NbExp=2; IntAct=EBI-359815, EBI-593303;
CC       Q8WYL5:SSH1; NbExp=3; IntAct=EBI-359815, EBI-1222387;
CC       Q91YE8:Synpo2 (xeno); NbExp=3; IntAct=EBI-359815, EBI-7623057;
CC       P49815:TSC2; NbExp=4; IntAct=EBI-359815, EBI-396587;
CC       P46937:YAP1; NbExp=6; IntAct=EBI-359815, EBI-1044059;
CC       P62258:YWHAE; NbExp=4; IntAct=EBI-359815, EBI-356498;
CC       P61981:YWHAG; NbExp=2; IntAct=EBI-359815, EBI-359832;
CC       P27348:YWHAQ; NbExp=2; IntAct=EBI-359815, EBI-359854;
CC       P22893:Zfp36 (xeno); NbExp=5; IntAct=EBI-359815, EBI-647803;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17081065}.
CC       Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P31946-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P31946-2; Sequence=VSP_018632;
CC         Note=Contains a N-acetylmethionine at position 1.
CC         {ECO:0000244|PubMed:22814378};
CC   -!- PTM: The alpha, brain-specific form differs from the beta form in
CC       being phosphorylated. Phosphorylated on Ser-60 by protein kinase C
CC       delta type catalytic subunit in a sphingosine-dependent fashion.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
DR   EMBL; X57346; CAA40621.1; -; mRNA.
DR   EMBL; AK292717; BAF85406.1; -; mRNA.
DR   EMBL; AL008725; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75893.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75894.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75896.1; -; Genomic_DNA.
DR   EMBL; BC001359; AAH01359.1; -; mRNA.
DR   CCDS; CCDS13339.1; -. [P31946-1]
DR   PIR; S34755; S34755.
DR   RefSeq; NP_003395.1; NM_003404.4. [P31946-1]
DR   RefSeq; NP_647539.1; NM_139323.3. [P31946-1]
DR   RefSeq; XP_016883528.1; XM_017028039.1. [P31946-1]
DR   UniGene; Hs.643544; -.
DR   PDB; 2BQ0; X-ray; 2.50 A; A/B=2-239.
DR   PDB; 2C23; X-ray; 2.65 A; A=2-239.
DR   PDB; 4DNK; X-ray; 2.20 A; A/B=1-246.
DR   PDB; 5N10; X-ray; 1.60 A; A/B=1-246.
DR   PDB; 6BYK; X-ray; 3.00 A; A/B/C/D=3-232.
DR   PDBsum; 2BQ0; -.
DR   PDBsum; 2C23; -.
DR   PDBsum; 4DNK; -.
DR   PDBsum; 5N10; -.
DR   PDBsum; 6BYK; -.
DR   ProteinModelPortal; P31946; -.
DR   SMR; P31946; -.
DR   BioGrid; 113361; 369.
DR   CORUM; P31946; -.
DR   DIP; DIP-743N; -.
DR   ELM; P31946; -.
DR   IntAct; P31946; 276.
DR   MINT; P31946; -.
DR   STRING; 9606.ENSP00000300161; -.
DR   ChEMBL; CHEMBL3710403; -.
DR   iPTMnet; P31946; -.
DR   PhosphoSitePlus; P31946; -.
DR   SwissPalm; P31946; -.
DR   DMDM; 1345590; -.
DR   OGP; P31946; -.
DR   REPRODUCTION-2DPAGE; IPI00216318; -.
DR   EPD; P31946; -.
DR   PaxDb; P31946; -.
DR   PeptideAtlas; P31946; -.
DR   PRIDE; P31946; -.
DR   TopDownProteomics; P31946-1; -. [P31946-1]
DR   TopDownProteomics; P31946-2; -. [P31946-2]
DR   DNASU; 7529; -.
DR   Ensembl; ENST00000353703; ENSP00000300161; ENSG00000166913. [P31946-1]
DR   Ensembl; ENST00000372839; ENSP00000361930; ENSG00000166913. [P31946-1]
DR   GeneID; 7529; -.
DR   KEGG; hsa:7529; -.
DR   CTD; 7529; -.
DR   DisGeNET; 7529; -.
DR   EuPathDB; HostDB:ENSG00000166913.12; -.
DR   GeneCards; YWHAB; -.
DR   HGNC; HGNC:12849; YWHAB.
DR   HPA; CAB003759; -.
DR   HPA; HPA007925; -.
DR   HPA; HPA011212; -.
DR   MIM; 601289; gene.
DR   neXtProt; NX_P31946; -.
DR   OpenTargets; ENSG00000166913; -.
DR   PharmGKB; PA37438; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   GeneTree; ENSGT00760000119116; -.
DR   HOGENOM; HOG000240379; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P31946; -.
DR   KO; K16197; -.
DR   OMA; KKQQMGR; -.
DR   OrthoDB; EOG091G0VKY; -.
DR   PhylomeDB; P31946; -.
DR   TreeFam; TF102003; -.
DR   Reactome; R-HSA-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-HSA-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   Reactome; R-HSA-165159; mTOR signalling.
DR   Reactome; R-HSA-166208; mTORC1-mediated signalling.
DR   Reactome; R-HSA-170968; Frs2-mediated activation.
DR   Reactome; R-HSA-170984; ARMS-mediated activation.
DR   Reactome; R-HSA-2028269; Signaling by Hippo.
DR   Reactome; R-HSA-392517; Rap1 signalling.
DR   Reactome; R-HSA-450385; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA.
DR   Reactome; R-HSA-450513; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5673000; RAF activation.
DR   Reactome; R-HSA-5674135; MAP2K and MAPK activation.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802948; Signaling by high-kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   Reactome; R-HSA-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   SignaLink; P31946; -.
DR   SIGNOR; P31946; -.
DR   ChiTaRS; YWHAB; human.
DR   EvolutionaryTrace; P31946; -.
DR   GeneWiki; YWHAB; -.
DR   GenomeRNAi; 7529; -.
DR   PRO; PR:P31946; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000166913; Expressed in 246 organ(s), highest expression level in endothelial cell.
DR   CleanEx; HS_YWHAB; -.
DR   ExpressionAtlas; P31946; baseline and differential.
DR   Genevisible; P31946; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Ensembl.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL.
DR   GO; GO:0050815; F:phosphoserine residue binding; IPI:BHF-UCL.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IDA:BHF-UCL.
DR   GO; GO:0035329; P:hippo signaling; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IMP:UniProtKB.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IDA:BHF-UCL.
DR   GO; GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Host-virus interaction;
KW   Isopeptide bond; Nitration; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN         1    246       14-3-3 protein beta/alpha.
FT                                /FTId=PRO_0000367900.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:25489052,
FT                                ECO:0000269|Ref.7}.
FT   CHAIN         2    246       14-3-3 protein beta/alpha, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000000003.
FT   SITE         58     58       Interaction with phosphoserine on
FT                                interacting protein. {ECO:0000250}.
FT   SITE        129    129       Interaction with phosphoserine on
FT                                interacting protein. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine; in 14-3-3 protein
FT                                beta/alpha; alternate.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES       2      2       N-acetylthreonine; in 14-3-3 protein
FT                                beta/alpha, N-terminally processed.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:25489052,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES       2      2       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES       5      5       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      51     51       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES      70     70       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      84     84       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES     106    106       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES     117    117       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P68251}.
FT   MOD_RES     232    232       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CROSSLNK     51     51       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   VAR_SEQ       1      2       Missing (in isoform Short).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018632.
FT   VARIANT      99     99       V -> I (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064762.
FT   HELIX         5     17       {ECO:0000244|PDB:5N10}.
FT   HELIX        21     32       {ECO:0000244|PDB:5N10}.
FT   HELIX        40     70       {ECO:0000244|PDB:5N10}.
FT   TURN         73     75       {ECO:0000244|PDB:5N10}.
FT   HELIX        78    105       {ECO:0000244|PDB:5N10}.
FT   TURN        106    110       {ECO:0000244|PDB:5N10}.
FT   HELIX       114    134       {ECO:0000244|PDB:5N10}.
FT   HELIX       137    161       {ECO:0000244|PDB:5N10}.
FT   HELIX       167    182       {ECO:0000244|PDB:5N10}.
FT   HELIX       187    203       {ECO:0000244|PDB:5N10}.
FT   HELIX       204    207       {ECO:0000244|PDB:5N10}.
FT   TURN        210    212       {ECO:0000244|PDB:5N10}.
FT   HELIX       213    231       {ECO:0000244|PDB:5N10}.
SQ   SEQUENCE   246 AA;  28082 MW;  6BE1A9BF97468017 CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLIPN ATQPESKVFY
     LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
ID   001R_FRG3G              Reviewed;         256 AA.
AC   Q6GZX4;
DT   28-JUN-2011, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   27-SEP-2017, entry version 33.
DE   RecName: Full=Putative transcription factor 001R;
GN   ORFNames=FV3-001R;
OS   Frog virus 3 (isolate Goorha) (FV-3).
OC   Viruses; dsDNA viruses, no RNA stage; Iridoviridae; Alphairidovirinae;
OC   Ranavirus.
OX   NCBI_TaxID=654924;
OH   NCBI_TaxID=8295; Ambystoma (mole salamanders).
OH   NCBI_TaxID=30343; Dryophytes versicolor (chameleon treefrog).
OH   NCBI_TaxID=8404; Lithobates pipiens (Northern leopard frog) (Rana pipiens).
OH   NCBI_TaxID=8316; Notophthalmus viridescens (Eastern newt) (Triturus viridescens).
OH   NCBI_TaxID=45438; Rana sylvatica (Wood frog).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15165820; DOI=10.1016/j.virol.2004.02.019;
RA   Tan W.G., Barkman T.J., Gregory Chinchar V., Essani K.;
RT   "Comparative genomic analyses of frog virus 3, type species of the
RT   genus Ranavirus (family Iridoviridae).";
RL   Virology 323:70-84(2004).
CC   -!- FUNCTION: Transcription activation. {ECO:0000305}.
DR   EMBL; AY548484; AAT09660.1; -; Genomic_DNA.
DR   RefSeq; YP_031579.1; NC_005946.1.
DR   ProteinModelPortal; Q6GZX4; -.
DR   SwissPalm; Q6GZX4; -.
DR   GeneID; 2947773; -.
DR   KEGG; vg:2947773; -.
DR   OrthoDB; VOG090000I8; -.
DR   Proteomes; UP000008770; Genome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0046782; P:regulation of viral transcription; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR007031; Poxvirus_VLTF3.
DR   Pfam; PF04947; Pox_VLTF3; 1.
PE   4: Predicted;
KW   Activator; Complete proteome; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    256       Putative transcription factor 001R.
FT                                /FTId=PRO_0000410512.
FT   COMPBIAS     14     17       Poly-Arg.
SQ   SEQUENCE   256 AA;  29735 MW;  B4840739BF7D4121 CRC64;
     MAFSAEDVLK EYDRRRRMEA LLLSLYYPND RKLLDYKEWS PPRVQVECPK APVEWNNPPS
     EKGLIVGHFS GIKYKGEKAQ ASEVDVNKMC CWVSKFKDAM RRYQGIQTCK IPGKVLSDLD
     AKIKAYNLTV EGVEGFVRYS RVTKQHVAAF LKELRHSKQY ENVNLIHYIL TDKRVDIQHL
     EKDLVKDFKA LVESAHRMRQ GHMINVKYIL YQLLKKHGHG PDGPDILTVK TGSKGVLYDD
     SFRKIYTDLG WKFTPL
//
ID   S5MDA5_9EURY            Unreviewed;       608 AA.
AC   S5MDA5; S5MW81;
DT   16-OCT-2013, integrated into UniProtKB/TrEMBL.
DT   16-OCT-2013, sequence version 1.
DT   05-DEC-2018, entry version 18.
DE   RecName: Full=DNA-directed RNA polymerase subunit beta {ECO:0000256|RuleBase:RU363031};
DE            EC=2.7.7.6 {ECO:0000256|RuleBase:RU363031};
OS   Salinirubrum litoreum.
OC   Archaea; Euryarchaeota; Stenosarchaea group; Halobacteria;
OC   Halobacteriales; Halobacteriaceae; Salinirubrum.
OX   NCBI_TaxID=1126234 {ECO:0000313|EMBL:AGR51007.1};
RN   [1] {ECO:0000313|EMBL:AGR51007.1}
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=YJ-63-S1 {ECO:0000313|EMBL:AGR51006.1}, and ZS-1-H
RC   {ECO:0000313|EMBL:AGR51007.1};
RA   Cui H.-L.;
RL   Submitted (JUL-2013) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:AGR51007.1}
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=YJ-63-S1 {ECO:0000313|EMBL:AGR51006.1}, and ZS-1-H
RC   {ECO:0000313|EMBL:AGR51007.1};
RX   PubMed=24158535; DOI=10.1007/s10482-013-0061-8;
RA   Cui H.L., Qiu X.X.;
RT   "Salinarubrum litoreum gen. nov., sp. nov.: a new member of the family
RT   Halobacteriaceae isolated from Chinese marine solar salterns.";
RL   Antonie Van Leeuwenhoek 105:135-141(2014).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription
CC       of DNA into RNA using the four ribonucleoside triphosphates as
CC       substrates. {ECO:0000256|RuleBase:RU363031}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate +
CC         RNA(n+1); Xref=Rhea:RHEA:21248, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:61557, ChEBI:CHEBI:83400, Rhea:RHEA-COMP:11128,
CC         Rhea:RHEA-COMP:11129; EC=2.7.7.6;
CC         Evidence={ECO:0000256|RuleBase:RU363031};
CC   -!- SIMILARITY: Belongs to the RNA polymerase beta chain family.
CC       {ECO:0000256|RuleBase:RU363031}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; KF316331; AGR51006.1; -; Genomic_DNA.
DR   EMBL; KF316332; AGR51007.1; -; Genomic_DNA.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0032549; F:ribonucleoside binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd00653; RNA_pol_B_RPB2; 1.
DR   Gene3D; 2.40.270.10; -; 1.
DR   Gene3D; 2.40.50.150; -; 1.
DR   InterPro; IPR015712; DNA-dir_RNA_pol_su2.
DR   InterPro; IPR007120; DNA-dir_RNAP_su2_dom.
DR   InterPro; IPR037033; DNA-dir_RNAP_su2_hyb_sf.
DR   InterPro; IPR007121; RNA_pol_bsu_CS.
DR   InterPro; IPR007646; RNA_pol_Rpb2_4.
DR   InterPro; IPR007647; RNA_pol_Rpb2_5.
DR   InterPro; IPR007641; RNA_pol_Rpb2_7.
DR   InterPro; IPR014724; RNA_pol_RPB2_OB-fold.
DR   InterPro; IPR019969; RNAP_B.
DR   PANTHER; PTHR20856; PTHR20856; 1.
DR   Pfam; PF04566; RNA_pol_Rpb2_4; 1.
DR   Pfam; PF04567; RNA_pol_Rpb2_5; 1.
DR   Pfam; PF00562; RNA_pol_Rpb2_6; 1.
DR   Pfam; PF04560; RNA_pol_Rpb2_7; 1.
DR   TIGRFAMs; TIGR03670; rpoB_arch; 1.
DR   PROSITE; PS01166; RNA_POL_BETA; 1.
PE   3: Inferred from homology;
KW   DNA-directed RNA polymerase {ECO:0000256|RuleBase:RU363031};
KW   Nucleotidyltransferase {ECO:0000256|RuleBase:RU363031};
KW   Transcription {ECO:0000256|RuleBase:RU363031};
KW   Transferase {ECO:0000256|RuleBase:RU363031}.
FT   DOMAIN        9     70       RNA_pol_Rpb2_4. {ECO:0000259|Pfam:
FT                                PF04566}.
FT   DOMAIN       91    131       RNA_pol_Rpb2_5. {ECO:0000259|Pfam:
FT                                PF04567}.
FT   DOMAIN      139    511       RNA_pol_Rpb2_6. {ECO:0000259|Pfam:
FT                                PF00562}.
FT   DOMAIN      513    604       RNA_pol_Rpb2_7. {ECO:0000259|Pfam:
FT                                PF04560}.
SQ   SEQUENCE   608 AA;  67402 MW;  7BBE2443813F2F1D CRC64;
     MAQAREAKVY VNGSLVGTHP DPNQLAAQIR EARRRGDVSQ MVNVSVKERT GEVIVNADAG
     RARRPLIVVE NGEPLLDDEH VEAVQSGELS FEDLIERGYI EFIDAEEEED IYVAVDEDDL
     EPNHTHLEID PQLIFGIGAG MIPYPEHNAS PRITMGAGMM KQSLGLPAAN YRIRPDTRQH
     LLHYPQLSMV KTQTTEQIGF DERPAAQNFV VAVMSYEGFN IEDALVMNKG SVDRAMARSH
     FFRTYEGEER RYPGGQEDRF EIPSQDVRGA RGEDAYTHLD EDGLVNPETV VDENSVLLGK
     TSPPRFLEEP DDMGGLSPQK RRETSVTMRS GEDGVVDTVT LMEGEDGSKL SKVSVRDERI
     PELGDKFASR HGQKGVVGHL APQEDMPFTQ EGVVPDLVLN PHALPSRMTV GHVLEMLGGK
     VGALEGRRVD GTAFQGENED ELRGALEDHG FKSSGKEVMY SGVTGEKIDA EIFVGTIFYH
     KLYHMVSNKL HARSRGPVQV LTRQPTEGRA REGGLRVGEM EREVLIGHGA AMALKERLLD
     SSDREFIEVC GNCGMSAVEN VEQRRVYCPN CGEETDIHEI EMSYAFKLLL DEMKALGIAP
     RLKLEDAV
//
ID   A0A346RQC0_9ARCH        Unreviewed;       210 AA.
AC   A0A346RQC0;
DT   07-NOV-2018, integrated into UniProtKB/TrEMBL.
DT   07-NOV-2018, sequence version 1.
DT   05-DEC-2018, entry version 2.
DE   SubName: Full=Ammonia monooxygenase factor A1-3-2-a {ECO:0000313|EMBL:AXS75565.1};
DE   SubName: Full=Ammonia monooxygenase factor A3-6-a {ECO:0000313|EMBL:AXS75538.1};
DE   Flags: Fragment;
GN   Name=amoA {ECO:0000313|EMBL:AXS75538.1};
OS   uncultured soil archaeon.
OC   Archaea; environmental samples.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AXS75538.1};
RN   [1] {ECO:0000313|EMBL:AXS75538.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Huang R., Wang Y.;
RT   "Effect of agricultural managements on soil microbial diversity and
RT   abundance in arable soil.";
RL   Submitted (APR-2018) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; MH200779; AXS75538.1; -; Genomic_DNA.
DR   EMBL; MH200806; AXS75565.1; -; Genomic_DNA.
DR   GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1450.10; -; 1.
DR   InterPro; IPR024656; AmoA_arc.
DR   InterPro; IPR037001; NH3/CH4_mOase_suA_sf.
DR   Pfam; PF12942; Archaeal_AmoA; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Monooxygenase {ECO:0000313|EMBL:AXS75538.1};
KW   Oxidoreductase {ECO:0000313|EMBL:AXS75538.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM      9     31       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     95    114       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    121    145       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    179    198       Helical. {ECO:0000256|SAM:Phobius}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AXS75538.1}.
FT   NON_TER     210    210       {ECO:0000313|EMBL:AXS75538.1}.
SQ   SEQUENCE   210 AA;  23444 MW;  DC9D9BA72A9655B1 CRC64;
     VWLRRTTHYL FIVVVAVNST LLTINAGDYI FYTDWAWTSF VVFSISQSTM LVVGAIYYML
     FTGVPGTATY YATIMTIYTW VAKGAWFALG YPYDFITVPV WIPSAMLLDL TYWATRRNKH
     AAIIIGGTLV GLSLPMFNMI NLLLIRDPLE VAFKYPRPTL PPYMTPIEPQ VGKFYNSPVA
     LGAGAGAVLS VPIAALGAKL NTWTYRWMAA
//
